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Abstract: Hydrogen sulfide (H2S) is an endogenous mediator, synthesized from L-cysteine by
cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS) or 3-mercaptopyruvate sulfurtransferase
(3-MST). The mechanism(s) involved in H2S-gastroprotection against ischemia/reperfusion (I/R)
lesions and their time-dependent progression into deeper gastric ulcerations have been little studied.
We determined the effect of L-cysteine, H2S-releasing NaHS or slow H2S releasing compound
GYY4137 on gastric blood flow (GBF) and gastric lesions induced by 30 min of I followed by 3,
6, 24 and 48 h of R. Role of endogenous prostaglandins (PGs), afferent sensory nerves releasing
calcitonin gene-related peptide (CGRP), the gastric expression of hypoxia inducible factor (HIF)-1α
and anti-oxidative enzymes were examined. Rats with or without capsaicin deactivation of sensory
nerves were pretreated i.g. with vehicle, NaHS (18–180 µmol/kg) GYY4137 (90 µmol/kg) or
L-cysteine (0.8–80 µmol/kg) alone or in combination with (1) indomethacin (14 µmol/kg i.p.), SC-560
(14 µmol/kg), celecoxib (26 µmol/kg); (2) capsazepine (13 µmol/kg i.p.); and (3) CGRP (2.5 nmol/kg
i.p.). The area of I/R-induced gastric lesions and GBF were measured by planimetry and H2-gas
clearance, respectively. Expression of mRNA for CSE, CBS, 3-MST, HIF-1α, glutathione peroxidase
(GPx)-1, superoxide dismutase (SOD)-2 and sulfide production in gastric mucosa compromised by I/R
were determined by real-time PCR and methylene blue method, respectively. NaHS and L-cysteine
dose-dependently attenuated I/R-induced lesions while increasing the GBF, similarly to GYY4137
(90 µmol/kg). Capsaicin denervation and capsazepine but not COX-1 and COX-2 inhibitors reduced
NaHS- and L-cysteine-induced protection and hyperemia. NaHS increased mRNA expression for
SOD-2 and GPx-1 but not that for HIF-1α. NaHS which increased gastric mucosal sulfide release,
prevented further progression of acute I/R injury into deeper gastric ulcers at 6, 24 and 48 h of
R. We conclude that H2S-induced gastroprotection against I/R-injury is due to increase in gastric
microcirculation, anti-oxidative properties and afferent sensory nerves activity but independent on
endogenous prostaglandins.
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1. Introduction
Hydrogen sulfide (H2S) plays an important role as intracellular gaseous transmitter and
contributes to many physiological and pathological processes [1,2]. This molecule exerts vasoactive
activity similarly to nitric oxide (NO) and carbon monoxide (CO), all three considered to act as
endogenous gaseous mediators [3–6]. Moreover, H2S similarly to NO, inhibits leukocytes adherence
to blood vessel wall [7]. Endogenous H2S is synthesized from L-cysteine by the activity of two
main pirydoxal-5-phosphate (P5P, vitamin B6) dependent enzymes: cystathionine γ-lyase (CSE) and
cystathionine β-synthase (CBS) [8,9] or by 3-mercaptopyruvate sulfurtransferase (3-MST) in co-activity
with cysteine aminotransferase [10].
H2S plays an important role in the regulation of the physiological functions of gastrointestinal
(GI) tract and the mechanism of GI-integrity maintenance [11]. Physiologically, H2S regulates Cl−
ion secretion by activating Ca2+ and ATP-sensitive K+ channels in rat colon [12]. In another study,
Ise et al. [13] have demonstrated that NaHS, a H2S donor, dose-dependently increased HCO3− ion
secretion in rats’ small intestine. On the other hand, recent data has shown that H2S may be involved
in human colon cancer cell proliferation and this mechanism is accompanied by a decrease of NO
production [14]. In contrast, it has been reported that diallyl disulfide, a H2S donor, dose-dependently
inhibited HT29 human colon cancer cells proliferation indicating that these discrepancies are dose
related [15]. Lou et al. [16] have shown that H2S inhibited the lipid peroxidation and formation of water
immersion and restraint stress-induced gastric damage. Wallace et al. [17] observed that treatment with
L-cysteine and H2S donors accelerated the healing of experimental chronic gastric ulcers. Furthermore,
H2S has been shown to prevent gastric mucosal damage induced by intragastric application of ethanol,
alendronate or non-steroidal anti-inflammatory drugs [6,18,19].
NaHS abrogated the gastric epithelial cells against I/R injury via mitogen-activated protein
kinase-dependent anti-apoptotic action and NF-κB-dependent anti-inflammatory pathway [20].
Moreover, NaHS attenuated harmful effect of short term I/R in rat gastric mucosa and this effect was
accompanied by upregulated superoxide dismutase (SOD) activity [21]. Mard et al. [22] observed
that the systemic (i.v.) administration of NaHS and L-cysteine attenuated gastric injury induced
by I/R. Despite these reports concerning the effect of NaHS in the upper and lower GI-tract, the
potential role of this gaseous molecule in protection against gastric I/R injury and the mechanism
of its protective action has not been fully investigated. Little is known whether this endogenously
produced H2S can affect gastric lesions caused by I/R with the respect to their progression into deeper
gastric erosions caused by extending the time of reperfusion up to 12, 24 or 48 h. Moreover, the
potential gastroprotective effect of slowly H2S-releasing compound, GYY4137 against I/R-induced
gastric damage has not been so far investigated [23]. Furthermore, it remains unknown whether
the mechanism of H2S-mediated gastroprotection against this type of gastric mucosa injury involves
regulation of oxidation and hypoxia, activity of prostaglandins (PGs)/cyclooxygenases (COX) system,
afferent sensory nerves releasing calcitonin gene related peptide (CGRP) and vanilloid receptors
(TRPV)-1 activity.
2. Results
Exposure to I followed by 3 h of R caused the extensive hemorrhagic erosions in gastric mucosa
of rats pretreated with vehicle-control (Figure 1A). Figure 1B shows that the area of I/R-induced
gastric damage is reduced in rats pretreated with NaHS (90 µmol/kg i.g.) as compared with
vehicle-control (Figure 1B vs. Figure 1A). Similarly, I/R-induced gastric mucosa damage was
attenuated by pretreatment with H2S precursor, L-cysteine (Figure 1C vs. Figure 1A). Pretreatment
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with GYY4137 (90 µmol/kg i.g.) reduced I/R-induced gastric damage formation comparing with
vehicle-control (Figure 1D vs. Figure 1A).Molecules 2017, 22, 295 3 of 15 
 
Figure 1. Gross macroscopic appearance of gastric mucosa pretreated 30 min prior to gastric 
ischemia-reperfusion (I/R) with vehicle (A); NaHS (90 μmol/kg i.g.); (B), L-cysteine (80 μmol/kg i.g.); 
(C) or GYY4137 (90 μmol/kg i.g.); (D) and exposed to 30 min of I of celiac artery followed by 3 h of R (I/R).  
Pretreatment with NaHS (18–180 μmol/kg i.g.) and L-cysteine (0.8–80 μmol/kg i.g.) dose- 
dependently attenuated the area of gastric lesion and significantly increased the GBF in rats exposed 
to I followed by 3 h of R (Figure 2). The dose of NaHS and L-cysteine which reduced by 50% of the 
mean area of gastric lesion comparing with vehicle-control group was 90 and 80 mg/kg, respectively 
(p < 0.05). Pretreatment with GYY4137 administered i.g. in a dose of 90 μmol/kg, equimolar with the 
dose of NaHS inhibiting I/R-induced lesions by 50%, significantly decreased the area of I/R-induced 
gastric damage and significantly raised the GBF as compared with vehicle-control group (p < 0.05) 
(Figure 2). 
 
Figure 2. Mean lesion area and the GBF in gastric mucosa of rats pretreated with vehicle, NaHS (18–180 
μmol/kg i.g.), L-cysteine (0.8–80 μmol/kg i.g.) or GYY4137 (90 μmol/kg i.g.) and exposed to I followed 
by 3 h of R. Results are mean ± S.E.M of 4–5 rats per each experimental group. Significant changes as 
compared with the respective values in the vehicle-control group is indicated by an asterisk (p < 0.05). 
Figure 1. Gross macroscopic appearance of gastric mucosa pretreated 30 min prior to gastric
ischemia-repe fusion (I/R) with vehicle (A); NaHS (90 µmol/kg i.g.); (B), L-cysteine (80 µmol/kg i.g.);
(C) or GYY4137 (90 µmol/kg i.g.); (D) and exposed to 30 min of I of celiac artery followed by 3 h of
R (I/R).
Pretreatment with NaHS (18–180 µmol/kg i.g.) and L-cysteine (0.8–80 µmol/kg i.g.)
dose-dependently attenuated the area of gastric lesion and significantly increased the GBF in rats
exposed to I followed by 3 h of R (Figure 2). The dose of NaHS and L-cysteine which reduced by
50% of the mean area of gastric lesion comparing with vehicle-control group was 90 and 80 mg/kg,
respectively (p < 0.05). Pretreatment with GYY4137 administered i.g. in a dose of 90 µmol/kg,
equimolar with the dose of NaHS inhibiting I/R-induced lesions by 50%, significantly decreased the
area of I/R-induced gastric damage and significantly raised the GBF as compared with vehicle-control
group (p < 0.05) (Figure 2).
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Figure 2. Mean lesion area and the GBF in gastric mucosa of rats pretreated with vehicle, NaHS
(18–180 µmol/kg i.g.), L-cysteine (0.8–80 µmol/kg i.g.) or GYY4137 (90 µmol/kg i.g.) and exposed to I
followed by 3 h of R. Results ar mean ± S.E.M of 4–5 rats per each experimental group Significant
changes as compared with the respective values in the vehicle-control group is indicated by an asterisk
(p < 0.05).
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Figure 3 shows that co-administration of NaHS (90 µmol/kg i.g.) or L-cysteine (80 µmol/kg i.g.)
with 1) non-selective COX inhibitor, indomethacin (14 µmol/kg i.p.), 2) selective COX-1 inhibitor,
SC-560 (14 µmol/kg i.g.) or 3) selective COX-2 inhibitor, celecoxib (26 µmol/kg i.g.) (Figure 3A,B,
respectively) remained without a significant influence on the NaHS- and L-cysteine-induced decrease
in the area of I/R-induced gastric lesions and the accompanying increase in the GBF as compared with
the vehicle-pretreated control group (p < 0.05).
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values in the vehicle-control is indicated by asterisks (p < 0.05).  
Pretreatment with capsazepine (13 μmol/kg i.p.) which did not significantly increase the area of 
I/R-induced gastric damage and failed to significantly affect GBF, significantly increased the area of 
I/R-induced gastric lesions and significantly decreased the GBF evoked by NaHS or L-cysteine as 
compared with the groups treated with this H2S donor or H2S precursor alone (p < 0.05) (Figure 4). 
In groups of rats with capsaicin-induced deactivation of afferent sensory nerves, the area of I/R 
gastric lesions was significantly increased and the GBF was significantly decreased after pretreatment 
with NaHS (90 μmol/kg i.g.) or L-cysteine (80 μmol/kg i.g.) as compared with rats with intact-sensory 
nerves pretreated with this H2S donor or its precursor (p < 0.05) (Figure 5).  
The combination of NaHS or L-cysteine with CGRP (2.5 nmol/kg i.p.) which by itself significantly 
reduced the I/R injury and significantly increased the GBF in rats with capsaicin denervation, 
restored the values of area of I/R-induced gastric lesions and the GBF to those observed in groups of 
rats pretreated with NaHS or L-cysteine alone without capsaicin denervation (Figure 5). 
Figure 3. Mean lesion area and GBF in gastric mucosa of rats pretreated with vehicle, NaHS (A)
or L-cysteine (B) alone or in combination with indomethacin (INDO, 14 µmol/kg i.g.), SC-560
(14 µmol/kg i.p.) or celecoxib (CELE, 26 µmol/kg i.g.) and exposed to I followed by 3 h of R.
Results are mean ± S.E.M of 4–5 rats per each experimental group. A significant change as compared
with the respective values in the vehicle-control is indicated by asterisks (p < 0.05).
Pretreatment with capsazepine (13 µmol/kg i.p.) which did not significantly increase the area
of I/R-induced gastric damage and failed to significantly affect GBF, significantly increased the area
of I/R-induced gastric lesions and significantly decreased the GBF evoked by NaHS or L-cysteine as
compared with the groups treated with this H2S donor or H2S precursor alone (p < 0.05) (Figure 4).
In groups of rats with capsaicin-induced deactivation of afferent sensory nerves, the area of I/R
gastric lesions was significantly increased and the GBF was significantly decreased after pretreatment
with NaHS (90 µmol/kg i.g.) or L-cysteine (80 µmol/kg i.g.) as compared with rats with intact-sensory
nerves pretreated with this H2S donor or its precursor (p < 0.05) (Figure 5).
The combination of NaHS or L-cysteine with CGRP (2.5 nmol/kg i.p.) which by itself significantly
reduced the I/R injury and significantly increased the GBF in rats with capsaicin denervation, restored
the values of area of I/R-induced gastric lesions and the GBF to those observed in groups of rats
pretreated with NaHS or L-cysteine alone without capsaicin denervation (Figure 5).
Molecules 2017, 22, 295 5 of 16
Molecules 2017, 22, 295 5 of 15 
 
Figure 4. Mean lesion area and the GBF in rats pretreated with vehicle, NaHS (90 μmol/kg i.g.) or 
L-cysteine (80 μmol/kg i.g.) alone or in combination with capsazepine (13 μmol/kg i.p.) and exposed 
to I followed by 3 h of R. Results are mean ± S.E.M of 4–5 per each experimental group. Significant 
changes as compared with the respective values in the vehicle-control group are indicated by an 
asterisk (p < 0.05). A cross indicates a significant change compared to the values obtained in the 
group treated with NaHS and L-cysteine alone (p < 0.05). 
 
Figure 5. Effect of capsaicin denervation on the mean lesion area and GBF in rats exposed to 30 min 
of I followed by 3 h of R and pretreated with vehicle, NaHS (90 μmol/kg i.g.) or L-cysteine (80 μmol/kg 
i.g.) alone or in combination with CGRP (2.5 nmol/kg i.p.). Results are mean ± S.E.M of 4–5 rats per each 
experimental group. Significant change as compared with the respective values in vehicle-control 
group was indicated by asterisk (p < 0.05). Asterisks and crosses indicate significant changes compared 
to the values obtained in the group treated with saline, NaHS or L-cysteine without denervation (p < 0.05). 
A cross indicates a significant change as compared with the respective capsaicin-denervated animals 
without co-treatment with CGRP (p < 0.05).  
Figure 6 shows the mRNA expression for CSE (Figure 6A), CBS (Figure 6B) and 3-MST (Figure 6C) 
in rats pretreated with vehicle or NaHS (90 μmol/kg i.g.) and exposed to I followed by 3h of R. In rats 
pretreated with vehicle or NaHS, a significant increase of CSE mRNA expression was observed after 
exposure to I/R (p < 0.05) (Figure 6A). In the groups pretreated with vehicle or NaHS, a significant 
decrease of mRNA expression for CBS (Figure 6B) and 3-MST (Figure 6C) was observed after I 
followed by 3 h of R (p < 0.05). NaHS (90 μmol/kg i.g.) administered to intact rats failed to affect 
mRNA expression for CSE (Figure 6A), CBS (Figure 6B) and 3-MST (Figure 6C) as compared with 
the group of rats treated with vehicle-saline instead of NaHS.  
Figure 4. Mean lesion area and the GBF in rats pretreated with vehicle, NaHS (90 µmol/kg i.g.) or
L-cysteine (80 µmol/kg i.g.) alone or in combination with capsazepine (13 µ ol/kg i.p.) and exposed
to I followed by 3 h of R. Results are mean ± S.E.M of 4–5 per each experimental group. Significant
changes as compared with the respective values in the vehicle-control group are indicated by an asterisk
(p < 0.05). A cross indicates a significant change compared to the values obtained in the group treated
with NaHS and L-cysteine alone (p < 0.05).
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Figure 5. Effect f caps ici denervation on the mean lesion area and GBF in rats exposed to 30 min of
I followed by 3 h of R and pretreated with vehicle, NaHS (90 µmol/kg i.g.) or L-cysteine (80 µm l/kg
i.g.) alone or in combination with CGRP (2.5 nmol/kg i.p.). Results ar mean ± S.E.M of 4–5 rats p r
eac experiment l group. Si nificant change as compared with the r sp ctive valu s in vehicle-control
group was indicated by asterisk (p < 0.05). Asterisks and crosses indicate significant changes compared
to t e values obtai ed in the group treated with saline, NaHS or L-cysteine without denervation
(p < 0.05). A cross indicates a significant change as compared with the respective capsaicin-denervated
animals without co-treatment with CGRP (p < 0.05).
Figure 6 s ows the mR A expression for CSE (Figure 6A), CBS (Figure 6B) a d 3-MST (Figure 6C)
in rats pretreated with vehicle or NaHS (90 µmol/kg i.g.) and exposed to I followed by 3h of R. In rats
pretreated with vehicle or NaHS, a significant increase of CSE mRNA expression was observed after
exp sure to I/R (p < 0.05) (Figure 6A). In the groups pretreated with vehicle or NaHS, a significant
decrease of mRNA expression for CBS (Figure 6B) and 3-MST (Figure 6C) was observed after I
followed by 3 h of R (p < 0.05). NaHS (90 µmol/kg i.g.) administered to intact rats failed to affect
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mRNA expression for CSE (Figure 6A), CBS (Figure 6B) and 3-MST (Figure 6C) as compared with the
group of rats treated with vehicle-saline instead of NaHS.Molecules 2017, 22, 295 6 of 15 
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Results are mean ± S.E.M of 4–5 rats per each experimental group. An asterisk indicates a significant 
change as compared with intact rats (p < 0.05). A cross indicates a significant difference as compared 
with vehicle pretreated group (p < 0.05). 
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Figure 7 shows the mRNA expression for HIF-1α (Figure 7A), GPx-1 (Figure 7B) and SOD-2
(Figure 7C) in gastric mucosa of rats pretreated with vehicle or NaHS (90 µmol/kg i.g.) and exposed
to I followed by 3 h of R. In rats pretreated with vehicle and exposed to I/R, the mRNA expression
for HIF-1α, SOD-2 and GPx-1 was significantly decreased (p < 0.05) (Figure 7A–C). In groups
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pretreated with NaHS, the significant increase of GPx-1 (Figure 7B) and SOD-2 (Figure 7C) but
not HIF-1α (Figure 7A) mRNA expression was observed after I followed by 3 h of R as compared with
vehicle-control group (p < 0.05).Molecules 2017, 22, 295 7 of 15 
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Figure 8 shows that gastric damage area was significantly increased in groups of vehicle-pretreated 
animals exposed to I followed by 6 h of R as compared with those exposed to I followed by 3 h of R 
and pretreated with vehicle or NaHS (90 μmol/kg i.g.) (p < 0.05). 
Pretreatment with NaHS significantly decreased area of gastric I/R damage in groups exposed 
to I and followed by 3, 6, 24 or 48 h of R as compared to respective values recorded in vehicle-control 
group (p < 0.05). Pretreatment with NaHS accelerated the healing of I/R-induced gastric damage as 
demonstrated by a significant decrease in the area of gastric lesions in groups subjected to 24 and 48 h 
of R compared with the NaHS -pretreated groups exposed to 3 and 6 h of R (p < 0.05) (Figure 8). 
Figure 7. Expression of mRNA for HIF-1α (A), GPx-1 (B) and SOD-2 (C) in gastric mucosa of rats
exposed to I followed by 3 h of R and pretreated with vehicle (saline) or NaHS (90 µmol/kg i.g.).
Results are mean ± S.E.M of 4–5 rats per each experimental group. An asterisk indicates a significant
change as compared with intact rats (p < 0.05). A cross indicates a significant difference as compared
with the vehicle pretreated group (p < 0.05).
Figure 8 shows that gastric damage area was significantly increased in groups of vehicle-pretreated
animals exposed to I followed by 6 h of R as compared with those exposed to I followed by 3 h of R
and pretreated with ve icle or NaHS (90 µmol/kg i.g.) (p < 0.05).
Pretreatment with NaHS significantly decreased area of gastric I/R damage in groups exp sed to
I and followed by 3, 6, 24 or 48 h of R s compared to respective values recorded in vehicle-control
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group (p < 0.05). Pretreatment with NaHS accelerated the healing of I/R-induced gastric damage as
demonstrated by a significant decrease in the area of gastric lesions in groups subjected to 24 and 48 h
of R compared with the NaHS -pretreated groups exposed to 3 and 6 h of R (p < 0.05) (Figure 8).Molecules 2017, 22, 295 8 of 15 
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vehicle or NaHS and exposed to I fol o e fi l ase reached the values similar to
that obtained in intact rats.
Molecules 2017, 22, 295 8 of 15 
 
Figure 8. ean lesion area and the GBF in gastric mucosa of rats pretreated with single dose of 
vehicle or NaHS (90 μmol/kg i.g.) and exposed to 30 min of I followed by 3, 6, 24 and 48 h of R. 
Results are mean ± S.E. . of 4–5 rats per each group. An asterisk indicates a significant change as 
compared with the value obtained in the vehicle-control group exposed to I and 3 h of R (p < 0.05). 
Double asterisks denote a significant difference as compared with the values obtained in vehicle 
pretreated groups at respective times of R (p < 0.05). Crosses indicate a significant difference as 
compared with the values obtained in NaHS-pretreated groups at 3 h and 6 h of R, respectively  
(p < 0.05). 
Figure 9 sho s that pretreat ent ith a S (90 μ ol/kg i.g.) significantly increased sulfide 
release expressed as total sulfide pool fro  gastric ucosa exposed to I follo ed by 3, 6 and 24 h of 
R as co pared ith the ti e-respective vehicle-control groups (p < 0.05). In groups pretreated ith 
vehicle or a S and exposed to I follo ed by 48 h of R, sulfide release reached the values si ilar to 
that obtained in intact rats. 
 
Figure 9. Total sulfide pool released by CSE/CBS activity pathway in gastric mucosa of intact rats 
and those pretreated with vehicle (saline) or NaHS (90 μmol/kg i.g.) and exposed to I followed by 3, 
6, 24 or 48 h of R. Results are mean ± S.E.  of 4–5 rats per each experimental group. An asterisk 
indicates a significant change as compared with the value obtained in intact rats (p < 0.05). 
Figure 10 sho s that pretreat ent ith L-cysteine (80 μ ol/kg i.g.) or a S (90 μ ol/kg i.g.) 
significantly increased sulfide release by the activity of CSE/CBS path ay in gastric ucosa exposed 
to I and follo ed by 3 of R as co pared ith vehicle-control group (p < 0.05) (Figure 10A). 
Figure 9. Total sulfide pool released by CSE/CBS activity pathway in gastric mucosa of intact rats and
those pretreated with vehicle (saline) or NaHS (90 µmol/kg i.g.) and exposed to I followed by 3, 6, 24
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Figure 10 shows that pretreatment with L-cysteine (80 µmol/kg i.g.) or NaHS (90 µmol/kg i.g.)
significantly increased sulfide release by the activity of CSE/CBS pathway in gastric mucosa exposed
to I and followed by 3 of R as compared with vehicle-control group (p < 0.05) (Figure 10A).
Pretreatment with L-cysteine (80 µmol/kg i.g.) or NaHS (90 µmol/kg i.g.) did not affect sulfide
release by the 3-MST activity pathway in gastric mucosa exposed to I and followed by 3 of R as
compared with intact or vehicle-control group (p < 0.05) (Figure 10B).
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3. Discussion
Exposure of gastric mucosa to I/R is known to induce gastric mucosal hemorrhagic lesions due
to increased generation of reactive oxygen metabolites, microvascular dysfunction and adhesion of
neutrophils to the vascular endothelium and their infiltration of gastric mucosal structure [24–26].
After the R, the reactive oxygen species are generated, especially from xanthine–xanthine oxidase
system and ue to activated neutrophils, leading to enhancement in tissue lipid peroxidation, which
result in mucosal injury and cellular death [24,26,27]. As reported by our group reviously, these acute
I/R-induced gastric lesions can progress into deeper chronic ulcerations with the time extension of
reperfusion [28].
In this st dy, we investigated the involvement of H2S, exogenously delivered by the
administrati n of H2S donor, NaHS or slow H2S-releasing compound, GYY4137 [23] and that
end genously produced from L-cysteine, in the mecha ism of gastroprotection against the formation
of I/R-induced dam ge. Our second goal was to ex mine an effect of NaHS administrati n on
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further progression of these acute I/R lesions into deeper ulcerations by extension of the time of
R from initial 3 h up to 6 h, 1 day and 2 days, respectively. We determined the possible role of
H2S in restoration of gastric microcirculation and involvement of classic protective factors such as
endogenous prostaglandins and afferent sensory nerves releasing vasodilatory mediators such as
CGRP in H2S-mediated gastroprotection against I/R injury. We also attempted to assess if H2S released
from NaHS can affect changes of mRNA expression for anti-oxidative HIF-1α, GPx-1 and SOD-2
induced by exposure of gastric mucosa to I/R.
We observed that pretreatment with NaHS, H2S donor or L-cysteine, which acts as a H2S precursor,
dose-dependently reduced I/R-induced gastric damage and this effect was accompanied by restoration
of gastric microcirculation. Similar effect was observed when animals were pretreated with GYY4137
which has been considered as a slow releaser of H2S. These results are in pair with previous data that
the vasodilatory activity of H2S is involved in the mechanism of gastroprotection against stress-induced
lesions [29]. Our results are also in keeping with previous observations that H2S exerted protective
activity against I/R-induced gastric damage [21,22], hepatic I/R injury [30] and myocardial I/R
injury [31,32]. In addition, Meng et al. [33] reported that GYY4137 protects against myocardial I/R
injury. In this study, we have observed that CSE but not CBS or 3-MST mRNA expression in gastric
mucosa was elevated after exposure to I/R suggesting that in rat stomach injured by I/R, the H2S
can mainly derive from the activity of CSE biosynthetic pathway. Moreover, pretreatment with NaHS
or L-cysteine increased endogenous H2S production, possibly due to CSE activation since sulfide
release from gastric mucosa exposed to I/R and pretreated with NaHS or L-cysteine was increased via
CSE/CBS but not 3-MST activity pathway. Similarly, Bos et al. [34] demonstrated that CSE activity
could be considered as protective enzymatic pathway against renal damage caused by I/R.
Based on the evidence presented in this study, we propose that H2S gastroprotection against
I/R-induced injury does not depend on endogenous PGs biosynthesis by COX-1 or COX-2 activity
since the pharmacological inhibition of the activity of these enzymes failed to affect beneficial effect
of NaHS or L-cysteine observed in our present study. This seems to be contrary to the previous
observation in another experimental model of gastric damage because NaHS increased COX-1, COX-2
and PGE2 content and prevented gastric mucosa against stress-induced lesions [29]. Wallace et al. [35]
demonstrated that decreased H2S biosynthesis in rodent colon is associated with downregulation
of COX-2 mRNA expression. We assume that these discrepancies can be explained by the evident
differences in animal models and experimental conditions used in our and previous studies.
The mechanism of H2S-induced protection against I/R-injury involves the anti-oxidative
properties of this gaseous molecule since in our study the pretreatment with NaHS increased mRNA
expression for SOD-2 and GPx-1. On the other hand, in gastric mucosa compromised by I followed by
3 h of R, HIF-1α mRNA expression was also decreased. Indeed, previous studies reported that mRNA
expression of the gene for this particular protein was not affected in gastric mucosa when stomach
was subjected to standard I/R injury with an extension of reperfusion even up to 1 or 6 days [36].
In contrary, Wang et al. [37] reported that HIF-1α protein expression was increased in gastric mucosa
compromised by I and 6 h of R, suggesting that expression of this hypoxic factor in gastric mucosa
could be time of reperfusion-dependent. Our study revealed that pretreatment with NaHS failed to
affect downregulation of HIF-1α mRNA expression in gastric mucosa after standard 3 h of R. Therefore,
we conclude that H2S-mediated gastroprotection against this type of injury does not involve regulation
by HIF-1α.
On the other hand, we observed that, the gastroprotective effect of NaHS and L-cysteine was
attenuated in rats with capsaicin-induced sensory nerves ablation. The NaHS- and L-cysteine-mediated
gastroprotection in capsaicin-treated rats was then restored when CGRP was co-administered with H2S
donor or its metabolic precursor. Similarly to capsaicin-denervation, inhibition of TRPV1 activity by
capsazepine [38,39], although not completely, reversed gastroprotective effect of NaHS and L-cysteine.
Therefore, we assume that the mechanism of H2S-mediated regulation of gastric microcirculation and
gastroprotection against I/R-induced damage may depend upon the activation of TRPV1 receptors and
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the activity of afferent sensory nerves releasing vasodilatory CGRP. Based on these results obtained
in rats with capsaicin denervation and those with inhibited TRPV1 receptors by capsazepine, we
conclude that the potent vasodilatory and gastroprotective activity of H2S against I/R gastric lesions
may depend, at least in part, on activation by this gaseous molecule of sensory nerves and vanilloid
receptors. Since some degree of H2S protection was still observed in rats pretreated with capsazepine,
the possibility is not excluded that other factors i.e., nitric oxide (NO), potassium channels, guanylyl
cyclase/cGMP system, or yet unidentified factors can also mediate this protection and an increase
in the GBF observed in rats pretreated with H2S donor. Our notion that H2S protection involves
sensory nerves activation matches with data published recently that H2S-induced protection against
gastric oxidative bleeding erosions caused by another ulcerogen such as stress has been ameliorated
in animals with capsaicin-denervation [29]. Indeed, Lu et al. [40] provided direct evidence that H2S
modulates intestinal motility and excites duodenal contraction by the mechanism involving activation
of TRPV1 in afferent nerves endings and opening of KATP channels.
Interestingly, we observed that pretreatment with NaHS not only protected gastric mucosa against
the formation of I/R-induced lesions but also reduced development of gastric damage during their
progression to deeper gastric ulcerations and restored the decrease in GBF as observed after 6 h of R
in vehicle-pretreated animals exposed to I/R. Moreover, in groups pretreated with NaHS, almost no
gastric damage after 24 and 48 h of R has been observed. Furthermore, the exposure to I/R resulted
in upregulation of mRNA expression for CSE but downregulated CBS and 3-MST mRNA expression
in gastric mucosa and this effect was not affected by NaHS. Additionally, endogenous production
of H2S in gastric mucosa has been increased in rats pretreated with donor of this gaseous mediator.
We assume that elevated H2S bioavailability caused by the administration of NaHS releasing H2S
enhanced gastric mucosal resistance to oxidative I/R-induced gastric mucosal damage. Moreover,
H2S production in gastric tissue was maintained after 6 and 24 h of R. Thus, we conclude that H2S
can strengthen the mucosal barrier since this gaseous mediator not only reduced I/R-induced gastric
damage formation but also accelerated healing of these acute erosions progressing with time into
gastric ulceration. This supports the observation by Wallace et al. [17], who reported that treatment
with H2S donors accelerated the healing of pre-existing gastric ulcers.
4. Materials and Methods
4.1. Animals
Male Wistar rats (n= 150, average weight about 250 g) were used in the study. Rats were fasted
for 24 h with free access to drinking water before the exposure to I/R. The study was approved
by the Institutional Animal Care and Use Committee of Jagiellonian University Medical College in
Cracow and run in accordance with the statements of the Helsinki Declaration regarding handling of
experimental animals.
4.2. Experimental Design, I/R Injury, Afferent Sensory Nerves Ablation
Acute I/R gastric lesions were induced as described previously [28,41,42]. Briefly, under
pentobarbital anesthesia (60 mg/kg i.p.), the abdomen was opened, and the celiac artery was identified
and clamped for 30 min (I) followed by removal of the clamp to obtain R. After 3, 6, 24 and 48 h of
R, the area of gastric damage was measured by planimetry and the functional parameters described
below were determined.
Rats with intact sensory nerves (series A) were randomized to the groups (4–5 rats each) and
were administered 30 min before exposure to I/R with: (1) saline (vehicle-control group); (2) NaHS
(18–180 µmol/kg i.g.); (3) L-cysteine (0.8–80 µmol/kg i.g.); (4) GYY4137 (90 µmol/kg i.g.). The doses
of 90 and 80 µmol/kg i.g. for NaHS and L-cysteine, respectively, have been selected based on ability
of these compounds to reduce the area of I/R gastric damage by 50%. Separate groups of rats were
treated with saline or NaHS (90 µmol/kg i.g.) and were not exposed to I/R.
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Rats of series B were pretreated with capsazepine (5 mg/kg i.p.), TRPV1 blocker [38,39],
indomethacin (14 µmol/kg i.g.), non-selective COX inhibitor, SC-560 (14 µmol/kg i.g.), selective
COX-1 inhibitor or celecoxib (26 µmol/kg i.g.), selective COX-2 inhibitor alone or in combination with
NaHS (90 µmol/kg i.g.) or L-cysteine (80 µmol/kg i.g.) [29,43].
Two weeks before experiment, in separate group of rats (series C), capsaicin was administered
for three days at a dose of 82.5, 165 and 165 µmol/kg (total dose: 412.5 µmol/kg s.c.) to induce
functional ablation of afferent sensory nerves as described previously [42,44]. Next, rats of series C
were pretreated with vehicle, NaHS (90 µmol/kg i.g.) or L-cysteine (80 µmol/kg i.g.) alone or in
combination with CGRP (2.5 nmol/kg i.p.) and exposed to I/R.
In series D, rats were pretreated with vehicle or NaHS (90 µmol/kg i.g.) and were exposed to
I followed by 3, 6, 24 and 48 h of R to investigate the progression of I/R injury and changes in H2S
production in gastric mucosa. All tested compounds were of analytical grade and were purchased
from Sigma-Aldrich (Schelldorf, Germany).
4.3. Determination of I/R Lesions Area and Gastric Blood Flow Level (GBF)
After the end of I/R, the animals of series A–D were anesthetized with pentobarbital
(60 mg/kg i.p.), the abdomen was opened, and the stomach was exposed to measure GBF by H2 gas
clearance technique as described previously [45]. The GBF was measured in the fundic part of the
gastric mucosa not involving mucosal lesions. Average values of three measurements were determined
and expressed as a percentage of the change of the value determined in intact gastric mucosa of rat
stomach. The area of gastric lesions was determined with computerized planimetry (Morphomat,
Carl Zeiss, Berlin, Germany) by a person who did not know which experimental group the animals
belonged to.
4.4. Measurement of Sulfide Production in Gastric mucosa
Measurement of sulfide production in gastric mucosa was determined by modified methylene
blue-method, as described previously [17,19,29]. Briefly, gastric mucosa was quickly isolated,
snap-frozen, and stored at −80◦C. The gastric tissue was homogenized in ice-cold 50 mM potassium
phosphate buffer, pH = 8.0. L-cysteine (10 mM) and pyridoxal 5′-phosphate (P5P; 2 mM) or
α-ketoglutarate (α-KG; 2 mM) were added. H2S biosynthesis via CSE and CBS required the presence
of P5P, while that via 3-MST required α-KG. Tube containing a piece of filter paper soaked with zinc
acetate (1%; 0.3 mL) was placed inside the larger vial. The vials were then flushed with nitrogen gas
and capped with an airtight serum cap. The vials were then transferred to water bath (37 ◦C) and after
90 min, trichloroacetic acid (TCA; 50%; 0.5 mL was injected into the reaction mixture through the serum
cap. The mixture remained to stand for 60 min. N,N-dimethyl-p-phenylenediamine sulfate (20 mM;
50 µL) in 7.2 M HCl and FeCl3 (30 mM; 50 µL) in 1.2 M HCl were added. After 20 min, absorbance
at 670 nm was measured with a microplate reader (Tecan Sunrise, Männedorf, Switzerland). The
calibration curve of absorbance vs. H2S concentration was obtained by using NaHS solution of varying
concentrations. Results were expressed as total sulfide pool released from 1 g of gastric mucosa per
one hour.
4.5. Determination of mRNA Expression for CSE, CBS, 3-MST, HIF-1α, GPx-1, SOD-2 in Gastric Mucosa by
Real Time Polymerase Chain Reaction (PCR)
Gastric mucosa from rats exposed to I/R and pretreated with vehicle or NaHS (5 mg/kg i.g.)
was collected, snap-frozen in liquid nitrogen and stored at −80◦C for further determination of
mRNA expression for CSE, CBS, MST, HIF-1α, GPx-1, SOD-2 by real time PCR, as described
previously [18,19,46].
Total RNA was isolated using commercially available kit with spin-columns (GeneMATRIX
Universal RNA Purification Kit, EURx, Gdansk, Poland) according to manufacturer protocol.
Reversed transcription was performed using High-Capacity cDNA Reverse Transcription Kit with
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RNAse inhibitor (MultiScribe™, Applied Biosystems, Life Technologies, Carlsbad, CA, USA) and
random primers.
Expression for CSE, CBS, MST, HIF-1α, GPx-1, SOD-2 and β-actin as reference gene was
determined using specific primers [18,19]. The real time PCR was conducted using thermal cycler
Quant Studio 12K Flex (Thermo Fisher Scientific, Waltham, MA, USA) and SYBR Green dye including
kit (SG qPCR Master Mix (2x), EURx). Results were analyzed using the 2−∆Ct method [47,48].
4.6. Statistical Analysis
Results of the experiment were expressed as mean ± S.E.M and the statistical analysis was
performed with t-Student test or ANOVA test and Tukey post-hoc test where appropriate. p < 0.05 was
considered as statistically significant.
5. Conclusions
We conclude that H2S released form NaHS or produced endogenously form L-cysteine mainly
due to CSE activity acts as an important, protective factor in gastric mucosa against I/R-induced
gastric damage which can also accelerate the healing of these erosions. The mechanism of this
H2S-mediated gastroprotection does not involve the endogenous PGs biosynthesis and regulation
of HIF-1α expression but may depend upon the vasodilatory properties of this gaseous molecule
mediated by the activity of CGRP-releasing afferent sensory nerves, finally leading to increase in gastric
microcirculation under conditions associated with the generation of reactive oxygen metabolites and
the enhanced oxidative metabolism.
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